Georgia vs Republic of Korea: Share of E. coli infections resistant to cephalosporins
Georgia
46.5%
in 2022
Republic of Korea
38.8%
in 2022
Georgia rank
18th
Republic of Korea rank
21st
Share of E. coli infections resistant to cephalosporins over time
- Georgia
- Republic of Korea
How they compare
Georgia currently reports 46.5% against 38.8% in Republic of Korea, a difference of 7.7%.
That makes Georgia's figure about 1.2 times Republic of Korea's.
The two have swapped places 2 times across 6 shared years of data; in 2017 it was Georgia ahead.
Georgia ranks 18th and Republic of Korea ranks 21st of 46 countries.
Georgia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Georgia | Republic of Korea | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 53.1% | 36.0% | 17.1% | Georgia |
| 2020s | 41.8% | 37.7% | 4.1% | Georgia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of e. coli infections resistant to cephalosporins, Georgia or Republic of Korea?
- Georgia, at 46.5% against 38.8% in Republic of Korea as of 2022.
- What is the difference in share of e. coli infections resistant to cephalosporins between Georgia and Republic of Korea?
- 7.7%, with Georgia ahead.
- How many years of comparable data are there for Georgia and Republic of Korea?
- 6 years are reported by both, from 2017 to 2022.
- How do Georgia and Republic of Korea rank globally for share of e. coli infections resistant to cephalosporins?
- Georgia ranks 18th and Republic of Korea ranks 21st of 46 countries.
- Where does this data come from?
- World Health Organization – processed by Our World in Data, published as Share of E. coli infections resistant to cephalosporins. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%).